4.4 Review

A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010

Related references

Note: Only part of the references are listed.
Article Biochemical Research Methods

Methodology for determining major constituents of ayahuasca and their metabolites in blood

Ethan H. McIlhenny et al.

BIOMEDICAL CHROMATOGRAPHY (2012)

Article Clinical Neurology

Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis

J. Daumann et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2010)

Article Multidisciplinary Sciences

The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator

Dominique Fontanilla et al.

SCIENCE (2009)

Article Biochemistry & Molecular Biology

When the Endogenous Hallucinogenic Trace Amine N,N-Dimethyltryptamine Meets the Sigma-1 Receptor

Tsung-Ping Su et al.

SCIENCE SIGNALING (2009)

Article Substance Abuse

The globalization of ayahuasca: Harm reduction or benefit maximization?

Kenneth W. Tupper

INTERNATIONAL JOURNAL OF DRUG POLICY (2008)

Article Psychology, Clinical

Drug tourism or spiritual healing? Ayahuasca seekers in Amazonia

M Winkelman

JOURNAL OF PSYCHOACTIVE DRUGS (2005)

Article Medicine, Research & Experimental

Potentially hallucinogenic 5-hydroxytryptamine receptor ligands bufotenine and dimethyltryptamine in blood and tissues

J Kärkkäinen et al.

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2005)

Article Pharmacology & Pharmacy

Human pharmacology of ayahuasca: Subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics

J Riba et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)